Jilin Aodong Pharmaceutical Group Co Ltd (000623) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.004x

Based on the latest financial reports, Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a cash flow conversion efficiency ratio of 0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥112.12 Million ≈ $16.41 Million USD) by net assets (CN¥30.82 Billion ≈ $4.51 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Jilin Aodong Pharmaceutical Group Co Ltd net asset quality index to measure how much of total assets are equity-financed.

Jilin Aodong Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Jilin Aodong Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 000623 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Jilin Aodong Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jilin Aodong Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
CSSC Offshore & Marine Engineering Group Co Ltd SHG:600685	-0.073x
Asker Healthcare ST:ASKER	0.061x
Avicopter PLC SHG:600038	-0.092x
Airoha Technology Corp TW:6526	0.071x
Concentra Group Holdings Parent, Inc. NYSE:CON	0.046x
Shyam Metalics and Energy Limited NSE:SHYAMMETL	0.031x
TOTVS S.A SA:TOTS3	0.058x
Westgold Resources Ltd AU:WGX	0.250x

Annual Cash Flow Conversion Efficiency for Jilin Aodong Pharmaceutical Group Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Jilin Aodong Pharmaceutical Group Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see Jilin Aodong Pharmaceutical Group Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥30.89 Billion ≈ $4.52 Billion	CN¥272.26 Million ≈ $39.84 Million	0.009x	+333.92%
2024-12-31	CN¥29.28 Billion ≈ $4.28 Billion	CN¥59.48 Million ≈ $8.70 Million	0.002x	-17.92%
2023-12-31	CN¥27.50 Billion ≈ $4.02 Billion	CN¥68.06 Million ≈ $9.96 Million	0.002x	-84.62%
2022-12-31	CN¥26.34 Billion ≈ $3.85 Billion	CN¥423.86 Million ≈ $62.02 Million	0.016x	+24.04%
2021-12-31	CN¥25.04 Billion ≈ $3.66 Billion	CN¥324.85 Million ≈ $47.54 Million	0.013x	-21.81%
2020-12-31	CN¥23.53 Billion ≈ $3.44 Billion	CN¥390.41 Million ≈ $57.13 Million	0.017x	-1.86%
2019-12-31	CN¥22.44 Billion ≈ $3.28 Billion	CN¥379.46 Million ≈ $55.53 Million	0.017x	+3.32%
2018-12-31	CN¥21.24 Billion ≈ $3.11 Billion	CN¥347.64 Million ≈ $50.87 Million	0.016x	+30.88%
2017-12-31	CN¥20.51 Billion ≈ $3.00 Billion	CN¥256.49 Million ≈ $37.53 Million	0.013x	-29.31%
2016-12-31	CN¥18.87 Billion ≈ $2.76 Billion	CN¥333.81 Million ≈ $48.85 Million	0.018x	-19.85%
2015-12-31	CN¥17.58 Billion ≈ $2.57 Billion	CN¥388.03 Million ≈ $56.78 Million	0.022x	-3.28%
2014-12-31	CN¥12.66 Billion ≈ $1.85 Billion	CN¥288.83 Million ≈ $42.26 Million	0.023x	+25.87%
2013-12-31	CN¥11.10 Billion ≈ $1.62 Billion	CN¥201.22 Million ≈ $29.44 Million	0.018x	-35.10%
2012-12-31	CN¥9.75 Billion ≈ $1.43 Billion	CN¥272.40 Million ≈ $39.86 Million	0.028x	+134.54%
2011-12-31	CN¥9.09 Billion ≈ $1.33 Billion	CN¥108.30 Million ≈ $15.85 Million	0.012x	-50.47%
2010-12-31	CN¥7.25 Billion ≈ $1.06 Billion	CN¥174.22 Million ≈ $25.49 Million	0.024x	-25.95%
2009-12-31	CN¥6.56 Billion ≈ $959.99 Million	CN¥213.03 Million ≈ $31.17 Million	0.032x	-28.95%
2008-12-31	CN¥5.14 Billion ≈ $752.55 Million	CN¥235.03 Million ≈ $34.39 Million	0.046x	-41.87%
2007-12-31	CN¥4.89 Billion ≈ $716.08 Million	CN¥384.69 Million ≈ $56.29 Million	0.079x	-2.34%
2006-12-31	CN¥2.34 Billion ≈ $341.74 Million	CN¥187.99 Million ≈ $27.51 Million	0.080x	-0.09%
2005-12-31	CN¥1.69 Billion ≈ $247.45 Million	CN¥136.26 Million ≈ $19.94 Million	0.081x	-39.83%
2004-12-31	CN¥1.63 Billion ≈ $238.80 Million	CN¥218.53 Million ≈ $31.98 Million	0.134x	+22.53%
2003-12-31	CN¥1.35 Billion ≈ $197.69 Million	CN¥147.65 Million ≈ $21.61 Million	0.109x	+3137.16%
2002-12-31	CN¥1.27 Billion ≈ $186.07 Million	CN¥-4.58 Million ≈ $-669.59K	-0.004x	-103.06%
2001-12-31	CN¥1.18 Billion ≈ $172.57 Million	CN¥138.76 Million ≈ $20.31 Million	0.118x	+68.14%
2000-12-31	CN¥1.10 Billion ≈ $161.09 Million	CN¥77.04 Million ≈ $11.27 Million	0.070x	-55.67%
1999-12-31	CN¥697.92 Million ≈ $102.13 Million	CN¥110.18 Million ≈ $16.12 Million	0.158x	+414.44%
1998-12-31	CN¥615.37 Million ≈ $90.05 Million	CN¥-30.90 Million ≈ $-4.52 Million	-0.050x	--

About Jilin Aodong Pharmaceutical Group Co Ltd

SHE:000623 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.09 Billion

CN¥21.13 Billion CNY

Market Cap Rank

#4744 Global

#766 in China

Share Price

CN¥17.67

Change (1 day)

-3.50%

52-Week Range

CN¥16.52 - CN¥21.82

All Time High

CN¥24.39